论文部分内容阅读
我们于1980年4月起开始试用灭活卡介苗(BCG)治疗支气管哮喘,经过5年临床观察,取得了一定的疗效。现将资料较完整的30例综合报告如下。一、临床资料男性12例,女性18例,共30例。其中1~9岁13例,10~19岁4例,20~29岁5例,30岁以上8例。病程最短1年,最长31年,平均9.2年。全年患病的有6例,不定时患病的有4例,冬季发病的14例,冬
We started in April 1980 trial of inactivated BCG treatment of bronchial asthma, after 5 years of clinical observation, and achieved some results. Now more complete information on the 30 cases are as follows. First, the clinical data of 12 males and 18 females, a total of 30 cases. Among them, 13 cases were 1 to 9 years old, 4 cases were 10 to 19 years old, 5 cases were 20 to 29 years old and 8 cases were over 30 years old. The shortest duration of 1 year, a maximum of 31 years, an average of 9.2 years. 6 cases of illness throughout the year, 4 cases of irregular illness, 14 cases of winter onset, winter